Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer.
J Endocr Soc. 2023 Sep 15;7(10):bvad117. doi: 10.1210/jendso/bvad117. eCollection 2023 Aug 28.
J Endocr Soc. 2023.
PMID: 37766843
Free PMC article.
Unlocking the Mysteries of Lobular Breast Cancer Biology Needs the Right Combination of Preclinical Models.
Bahnassy S, Sikora MJ, Riggins RB.
Bahnassy S, et al.
Mol Cancer Res. 2022 Jun 3;20(6):837-840. doi: 10.1158/1541-7786.MCR-22-0018.
Mol Cancer Res. 2022.
PMID: 35276005
Item in Clipboard
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer.
Bahnassy S, Stires H, Jin L, Tam S, Mobin D, Balachandran M, Podar M, McCoy MD, Beckman RA, Riggins RB.
Bahnassy S, et al.
Endocrinology. 2023 Nov 2;164(12):bqad159. doi: 10.1210/endocr/bqad159.
Endocrinology. 2023.
PMID: 37897495
Item in Clipboard
Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer.
Bahnassy S, Thangavel H, Quttina M, Khan AF, Dhanyalayam D, Ritho J, Karami S, Ren J, Bawa-Khalfe T.
Bahnassy S, et al.
Cell Commun Signal. 2020 Sep 18;18(1):154. doi: 10.1186/s12964-020-00649-z.
Cell Commun Signal. 2020.
PMID: 32948192
Free PMC article.
Item in Clipboard
Novel SUMO-Protease SENP7S Regulates β-catenin Signaling and Mammary Epithelial Cell Transformation.
Karami S, Lin FM, Kumar S, Bahnassy S, Thangavel H, Quttina M, Li Y, Ren J, Bawa-Khalfe T.
Karami S, et al. Among authors: bahnassy s.
Sci Rep. 2017 Apr 21;7:46477. doi: 10.1038/srep46477.
Sci Rep. 2017.
PMID: 28429743
Free PMC article.
Item in Clipboard
SUMOylation of HP1α supports association with ncRNA to define responsiveness of breast cancer cells to chemotherapy.
Lin FM, Kumar S, Ren J, Karami S, Bahnassy S, Li Y, Zheng X, Wang J, Bawa-Khalfe T.
Lin FM, et al. Among authors: bahnassy s.
Oncotarget. 2016 May 24;7(21):30336-49. doi: 10.18632/oncotarget.8733.
Oncotarget. 2016.
PMID: 27107417
Free PMC article.
Item in Clipboard
WNT4 Regulates Cellular Metabolism via Intracellular Activity at the Mitochondria in Breast and Gynecologic Cancers.
Sottnik JL, Shackleford MT, Robinson SK, Villagomez FR, Bahnassy S, Oesterreich S, Hu J, Madak-Erdogan Z, Riggins RB, Corr BR, Cook LS, Treviño LS, Bitler BG, Sikora MJ.
Sottnik JL, et al. Among authors: bahnassy s.
Cancer Res Commun. 2024 Jan 17;4(1):134-151. doi: 10.1158/2767-9764.CRC-23-0275.
Cancer Res Commun. 2024.
PMID: 38112643
Free PMC article.
Item in Clipboard
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer.
Bahnassy S, Stires H, Jin L, Tam S, Mobin D, Balachandran M, Podar M, McCoy MD, Beckman RA, Riggins RB.
Bahnassy S, et al.
bioRxiv [Preprint]. 2023 Aug 22:2023.08.21.554116. doi: 10.1101/2023.08.21.554116.
bioRxiv. 2023.
PMID: 37662291
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Cite
Cite